Issue

Vol. 35 No. 10 (2023): Vol 35 Issue 10, 2023

Copyright (c) 2023 N. SRAVANTHI, B. REVANTH, M. BHARGAVI, P. SARITA RAJENDER

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Synthesis, Characterization, Molecular Docking and Biological Evaluation of 1,4-Bis(aryl-1H- 1,2,3-triazole-4yl)methoxy)benzaldehyde Derivatives as Potential Anticancer Agents

https://doi.org/10.14233/ajchem.2023.28160
N. SRAVANTHI
Molecular Modeling Laboratory, Department of Chemistry, Nizam College, Osmania University, Hyderabad-500001, India
https://orcid.org/0000-0001-6014-6798
B. REVANTH
Molecular Modeling Laboratory, Department of Chemistry, Nizam College, Osmania University, Hyderabad-500001, India
https://orcid.org/0000-0002-5175-0456
M. BHARGAVI
1.Molecular Modeling Laboratory, Department of Chemistry, Nizam College, Osmania University, Hyderabad-500001, India 2. Department of Chemistry, St. Francis College for Women, Hyderabad-500016, India
https://orcid.org/0000-0001-9273-0315
P. SARITA RAJENDER
Department of Chemistry, University College of Engineering, Osmania University, Hyderabad-500007, India
https://orcid.org/0000-0002-6453-9705

Corresponding Author(s) : P. SARITA RAJENDER

saritarajender@gmail.com

Asian Journal of Chemistry, Vol. 35 No. 10 (2023): Vol 35 Issue 10, 2023

Abstract

A series of novel analogues of 1,4-bis((aryl-1H-1,2,3-triazole-4-yl)methoxy)benzaldehydes were synthesized efficiently by click reaction via conventional method using 2,4-dipropyloxy benzaldehyde and aryl azides characterized by spectroscopic methods including 1H NMR, 13C NMR, mass and IR spectrometry. Comparative molecular docking studies were carried out for all the synthesized compounds (4a-l) using cancer therapeutics levatinib and vandetanib targeting the VEGFR2 protein’s active region using the Glide tool in the Schrödinger suite. Among these, compounds 4b, 4f and 4h showed better drug likeness functions than current cancer inhibitors of VEGFR2 protein. Furthermore, to determine ADME and toxicity properties, the pkCSM server and the QikProp module were used. Glide scores and binding free energy analyses were used to determine the lead molecules. Compounds 4b, 4f and 4h revealed from docking exhibited potential in vitro cytotoxic activity against both MCF7 and HepG2 cell lines. 

Keywords

Click reaction Aryl azides Molecular docking Schrödinger suite MCF7 HepG2
SRAVANTHI, N., REVANTH, B., BHARGAVI, M., & RAJENDER, P. S. (2023). Synthesis, Characterization, Molecular Docking and Biological Evaluation of 1,4-Bis(aryl-1H- 1,2,3-triazole-4yl)methoxy)benzaldehyde Derivatives as Potential Anticancer Agents. Asian Journal of Chemistry, 35(10), 2554–2560. https://doi.org/10.14233/ajchem.2023.28160
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. S. Nanglia, M. Ahmad, F. Ali Khan and N.Z. Jhanjhi, Biomed. Signal Process. Control, 72, 103279 (2022); https://doi.org/10.1016/j.bspc.2021.103279
  2. J. Ferlay, M. Colombet, I. Soerjomataram, D.M. Parkin, M. Piñeros, A. Znaor and F. Bray, Int. J. Cancer, 149, 778 (2021); https://doi.org/10.1002/ijc.33588
  3. F. Gouzerh, J.-M. Bessière, B. Ujvari, F. Thomas, A.M. Dujon and L. Dormont, Biochim. Biophys. Acta Rev Cancer, 1877, 188644 (2022); https://doi.org/10.1016/j.bbcan.2021.188644
  4. P. Bhatt, M. Kumar and A. Jha, Mol. Divers., 22, 827 (2018); https://doi.org/10.1007/s11030-018-9832-5
  5. S. Bitla, A.A. Gayatri, M.R. Puchakayala, V. Kumar Bhukya, J. Vannada, R. Dhanavath, B. Kuthati, D. Kothula, S.R. Sagurthi and K.R. Atcha, Bioorg. Med. Chem. Lett., 41, 128004 (2021); https://doi.org/10.1016/j.bmcl.2021.128004
  6. H. Mousavi, Int. J. Biol. Macromol., 186, 1003 (2021); https://doi.org/10.1016/j.ijbiomac.2021.06.123
  7. A. Sahu, P. Sahu and R. Agrawal, Curr. Chem. Biol., 14, 71 (2020); https://doi.org/10.2174/2212796814999200807214519
  8. S. Kumar, S.L. Khokra and A. Yadav, Futur. J. Pharm. Sci., 7, 106 (2021); https://doi.org/10.1186/s43094-021-00241-3
  9. M.M. Alam, Arch. Pharm., 355, 2100158 (2022); https://doi.org/10.1002/ardp.202100158
  10. C.-Y. Cheng, A. Haque, M.-F. Hsieh, S. Imran Hassan, M.S. Faizi, N. Dege and M.S. Khan, Int. J. Mol. Sci., 21, 3823 (2020); https://doi.org/10.3390/ijms21113823
  11. K. Lal, P. Yadav, A. Kumar, A. Kumar and A.K. Paul, Bioorg. Chem., 77, 236 (2018); https://doi.org/10.1016/j.bioorg.2018.01.016
  12. I. Khan, M.A. Tantray, H. Hamid, M.S. Alam, A. Kalam, F. Hussain and A. Dhulap, Bioorg. Chem., 68, 41 (2016); https://doi.org/10.1016/j.bioorg.2016.07.007
  13. L.S. Feng, M.J. Zheng, F. Zhao and D. Liu, Arch. Pharm., 354, 2000163 (2021); https://doi.org/10.1002/ardp.202000163
  14. B. Zhang, Eur. J. Med. Chem., 168, 357 (2019); https://doi.org/10.1016/j.ejmech.2019.02.055
  15. C.-K. Chen, W.-H. Yu, T.-Y. Cheng, M.-W. Chen, C.-Y. Su, Y.-C. Yang, T.C. Kuo, M.T. Lin, Y.C. Huang, M. Hsiao, K.T. Hua, M.C. Hung and M.L. Kuo, Sci. Rep., 6, 31398 (2016); https://doi.org/10.1038/srep31398
  16. Q. Zhang, S. Lu, T. Li, L. Yu, Y. Zhang, H. Zeng, X. Qian, J. Bi and Y. Lin, J. Exp. Clin. Cancer Res., 38, 173 (2019); https://doi.org/10.1186/s13046-019-1156-5
  17. P. Prabhakaran, S. Kanagasabai, G. Seshan, K. Gugan, S. Usharani and P. Rajakumar, Chem. Data Coll., 28, 100427 (2020); https://doi.org/10.1016/j.cdc.2020.100427
  18. K.K. Mustyala, V. Malkhed, V.R. Chittireddy and U. Vuruputuri, Int. J. Mycobacteriol., 4, 330 (2015); https://doi.org/10.1016/j.ijmyco.2015.05.013
  19. M. Narasimha, B. Revanth, D. Mahender and P. Sarita Rajender, Biointerface Res. Appl. Chem., 11, 11088 (2020); https://doi.org/10.33263/BRIAC114.1108811103
  20. D.S. Goodsell, C. Zardecki, L. Di Costanzo, J.M. Duarte, B.P. Hudson, I. Persikova, J. Segura, C. Shao, M. Voigt, J.D. Westbrook, J.Y. Young and S.K. Burley, Protein Sci., 29, 52 (2020); https://doi.org/10.1002/pro.3730
  21. D.S. Goodsell and S.K. Burley, Oncogene, 39, 6623 (2020); https://doi.org/10.1038/s41388-020-01461-2
  22. P.C. Jilloju, P. Shyam, A. Sanjeev and R.R. Vedula, J. Mol. Struct., 1225, 129140 (2021); https://doi.org/10.1016/j.molstruc.2020.129140
  23. Glide, version 6.1. Schrödinger, NY: New York, LLC (2016).
  24. R.A. Friesner, J.L. Banks, R.B. Murphy, T.A. Halgren, J.J. Klicic, D.T. Mainz, M.P. Repasky, E.M. Knoll, M. Shelley, J.K. Perry, D.E. Shaw, P. Francis and P.S. Shenkin, J. Med. Chem., 47, 1739 (2004); https://doi.org/10.1021/jm0306430
  25. G. Lanka, R. Bathula, M. Dasari, M. Bhargavi and S.R. Potlapally, Int. J. Comput. Biol. Drug Des., 14, 166 (2021); https://doi.org/10.1504/IJCBDD.2021.117183
  26. E.A. Rifai, M. van Dijk, N.P. Vermeulen, A. Yanuar and D.P. Geerke, J. Chem. Inf. Model., 59, 4018 (2019); https://doi.org/10.1021/acs.jcim.9b00609
  27. B. Ji, S. Liu, X. He, V.H. Man, X.-Q. Xie and J. Wang, ACS Chem. Neurosci., 11, 1139 (2020); https://doi.org/10.1021/acschemneuro.9b00696
  28. QikProp, Schrodinger, NY: New York, LLC (2016).
  29. D.E. Pires, T.L. Blundell and D.B. Ascher, J. Med. Chem., 58, 4066 (2015); https://doi.org/10.1021/acs.jmedchem.5b00104
  30. A. Verma, K.N. Prasad, A.K. Singh, K.K. Nyati, R.K. Gupta and V.K. Paliwal, J. Microbiol. Methods, 81, 175 (2010); https://doi.org/10.1016/j.mimet.2010.03.001
  31. C.B. Pradeep Kumar, B.S. Prathibha, K.N.N. Prasad, M.S. Raghu, M.K. Prashanth, B.K. Jayanna, S. Chandrasekhar, H.D. Revanasiddappa, F.A. Alharthi and K.Y. Kumar, Bioorg. Med. Chem. Lett., 36, 127810 (2021); https://doi.org/10.1016/j.bmcl.2021.127810
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 0 Download : 1